| 000 | 01857 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514161936.0 | ||
| 264 | 0 | _c20040218 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 024 | 7 |
_a10.4049/jimmunol.171.10.5034 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHerrero, Carmen | |
| 245 | 0 | 0 |
_aReprogramming of IL-10 activity and signaling by IFN-gamma. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cNov 2003 |
||
| 300 |
_a5034-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xbiosynthesis |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGene Expression Regulation _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-10 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLipopolysaccharides _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMacrophage Activation _ximmunology |
| 650 | 0 | 4 | _aSTAT1 Transcription Factor |
| 650 | 0 | 4 | _aSTAT3 Transcription Factor |
| 650 | 0 | 4 |
_aSignal Transduction _ximmunology |
| 650 | 0 | 4 |
_aTrans-Activators _xbiosynthesis |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aUp-Regulation _ximmunology |
| 700 | 1 | _aHu, Xiaoyu | |
| 700 | 1 | _aLi, Wai Ping | |
| 700 | 1 | _aSamuels, Stuart | |
| 700 | 1 | _aSharif, M Nusrat | |
| 700 | 1 | _aKotenko, Sergei | |
| 700 | 1 | _aIvashkiv, Lionel B | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 171 _gno. 10 _gp. 5034-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4049/jimmunol.171.10.5034 _zAvailable from publisher's website |
| 999 |
_c14345454 _d14345454 |
||